Our Services
Medical Information
Helpful Resources
Published on: 9/17/2026
Zofran (ondansetron) usually begins relieving nausea within 30 minutes to 2 hours, with oral tablets and dissolvable films typically working in about 30 to 60 minutes, while an IV dose can start acting in as little as 5 to 15 minutes. Peak effect generally occurs around 2 hours after an oral dose, and relief often lasts 4 to 8 hours, which is why dosing is commonly repeated every 8 hours as directed. Timing varies based on your dose, form, whether you took it with food, your liver function, and the underlying cause of the nausea, so several important factors are worth reviewing below. If vomiting persists beyond 24 to 48 hours, or you notice signs of dehydration, severe abdominal pain, chest pain, an irregular heartbeat, or a fever, seek medical care promptly rather than waiting for the medication to take effect.
Because nausea can stem from anything from a stomach bug or migraine to pregnancy, medication side effects, or a more serious condition, understanding the cause matters as much as knowing how fast a drug works, and a free, instant, online symptom check can help you clarify what is likely going on and decide whether to treat at home, call your doctor, or seek urgent care today.
Last reviewed for medical accuracy: 09/17/2026
Zofran (ondansetron) is a widely prescribed medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, surgery and other medical conditions. As an expert doctor and human health writer, I’ll explain how Zofran works, when you can expect relief, factors that affect its onset, and what you can do while waiting for it to kick in.
Zofran belongs to a class of drugs called serotonin 5-HT3 receptor antagonists. It blocks serotonin signals in the gut and brain that trigger the vomiting reflex. By doing so, it helps reduce feelings of nausea and the urge to vomit.
Key points about Zofran:
How quickly Zofran works depends on how it’s given:
Oral Tablets and Oral Solution
Orally Disintegrating Tablets (ODT)
Intravenous (IV) Injection
| Formulation | Time to Onset | Peak Level (Tmax) |
|---|---|---|
| Oral tablet or solution | ~30 minutes | 1.5–2 hours |
| Orally disintegrating tablet | ~30 minutes | ~1.5 hours |
| IV injection | 30 seconds–2 minutes | Immediate |
Although the above times are averages, individual response may vary based on:
Most patients will notice some reduction in nausea within the following windows:
In clinical trials for chemotherapy-induced nausea and vomiting, a single 8 mg oral dose of ondansetron given 30 minutes before chemo prevented vomiting in a majority of patients during the first day of treatment. For post-operative use, a 4 mg IV dose given near the end of surgery reduced PONV in most patients within minutes.
Even though Zofran is effective, you can combine it with simple measures for extra relief:
Zofran is generally well tolerated, but be aware of potential side effects:
If you experience chest pain, fainting, irregular heartbeat, or severe allergic symptoms, seek medical attention immediately.
If you’re still feeling off or uncertain about the cause of your nausea, consider doing a free, online symptom check. The doctor-approved Ubie Symptom Checker can help you understand possible causes, suggest questions to ask your healthcare provider, and guide you on whether you need urgent care.
Always consult your doctor or pharmacist before starting or changing any medication. Speak to a doctor right away if you experience:
Your healthcare team knows your medical history and can tailor advice to keep you safe.
By understanding how long Zofran takes to work and following these tips, you can manage your nausea more effectively and get back to feeling like yourself. Always reach out to a healthcare professional for personalized advice.
(References)
* Peixoto AJ, Celich MF, Zardo L, Peixoto Filho AJ. Ondansetron or droperidol for prophylaxis of nausea and vomiting after intrathecal morphine. Eur J Anaesthesiol. 2006 Aug;23(8):670-5. doi: 10.1017/S0265021506000482. PMID: 16805932.
* Kovács G, Wachtel A, Basharova E, Spinelli T, Nicolas P, Kabickova E. Palonosetron compared with ondansetron in pediatric cancer patients: multicycle analysis of a randomized Phase III study. Future Oncol. 2017 Aug;13(19):1685-1698. doi: 10.2217/fon-2017-0189. Epub 2017 Jun 1. PMID: 28569078.
* Afzal A, Khan A, Khan A, Farooqi R, Khan BT, Ara I. Effect of paroxetine on intestinal motility in the presence of ondansetron. Pak J Pharm Sci. 2020 May;33(3):1169-1172. PMID: 33191244.
* Moore CC, Bledsoe LTR, Bonds CR, Keller M, King CH. Preventing Postoperative Nausea and Vomiting During an Ondansetron Shortage. AANA J. 2021 Apr;89(2):161-167. PMID: 33832577.
* Foth S, Meller S, Kenward H, Elliott J, Pelligand L, Volk HA. The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome. BMC Vet Res. 2021 Jun 21;17(1):222. doi: 10.1186/s12917-021-02931-9. Epub 2021 Jun 21. PMID: 34154584; PMCID: PMC8218477.
* Coulm B. [Nausea and vomiting in pregnancy: A place for ondansetron?]. Gynecol Obstet Fertil Senol. 2021 Dec;49(12):947-950. doi: 10.1016/j.gofs.2021.10.009. Epub 2021 Oct 23. PMID: 34700033.
* Jacobs SS, Dome JS, Gai J, Gross AM, Postell E, Hinds PS, Davenport L, van den Anker JN, Mowbray C. Pharmacogenetic and clinical predictors of ondansetron failure in a diverse pediatric oncology population. Support Care Cancer. 2022 Apr;30(4):3513-3520. doi: 10.1007/s00520-022-06818-9. Epub 2022 Jan 11. PMID: 35018520.
* Abdulhussain AS. Combination of dexamethasone and ondansetron in prophylaxis nausea and vomiting in gynecological operation. J Popul Ther Clin Pharmacol. 2022;29(4):e150-e157. doi: 10.47750/jptcp.2022.984. Epub 2022 Dec 3. PMID: 36464494.
* Reis ACC, Jorge BC, da Silva Moreira S, Stein J, Perdão CB, de Matos Manoel B, Arena AC. Embryo-fetal safety evaluation of ondansetron in rats. Birth Defects Res. 2023 Apr 1;115(6):605-613. doi: 10.1002/bdr2.2154. Epub 2023 Feb 3. PMID: 36737400.
* Kang Y, Koshika K, Takashima K, Nakakuki A, Hasunuma K, Hayashi M, Miyamoto K, Yamamoto M, Yoshida K, Ichinohe T. Dexamethasone and Ondansetron Combined Decreases Postoperative Nausea and Vomiting in Orthognathic Surgery Compared With Dexamethasone Alone: A Prospective Randomized Controlled Trial. Anesth Prog. 2025 Mar 12;72(1):3-8. doi: 10.2344/23-0019. Epub 2025 Mar 12. PMID: 40657837; PMCID: PMC11922510.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.